SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/08/19 Organovo Holdings, Inc. 10-Q 6/30/19 54:5M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 537K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 23K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 23K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 22K 11: R1 Document and Entity Information HTML 63K 12: R2 Condensed Consolidated Balance Sheets HTML 98K 13: R3 Condensed Consolidated Balance Sheets HTML 28K (Parenthetical) 14: R4 Unaudited Condensed Consolidated Statements of HTML 66K Operations and Other Comprehensive Loss 15: R5 Unaudited Condensed Consolidated Statements of HTML 45K Stockholders' Equity 16: R6 Unaudited Condensed Consolidated Statements of HTML 95K Cash Flows 17: R7 Description of Business HTML 23K 18: R8 Summary of Significant Accounting Policies HTML 59K 19: R9 Stockholders' Equity HTML 224K 20: R10 Collaborative Research, Development, and License HTML 24K Agreements 21: R11 Commitments and Contingencies HTML 24K 22: R12 Leases HTML 121K 23: R13 Concentrations HTML 22K 24: R14 Related Parties HTML 24K 25: R15 Subsequent Events HTML 24K 26: R16 Summary of Significant Accounting Policies HTML 76K (Policies) 27: R17 Stockholders' Equity (Tables) HTML 218K 28: R18 Leases (Tables) HTML 116K 29: R19 Summary of Significant Accounting Policies - HTML 74K Additional Information (Detail) 30: R20 Stockholders' Equity - Schedule of Stock-based HTML 27K Compensation Expense (Detail) 31: R21 Stockholders' Equity - Stock-based Compensation HTML 36K Expense and Valuation Information - Additional Information (Detail) 32: R22 Stockholders' Equity - Fair Value of Employee HTML 32K Stock Options (Detail) 33: R23 Stockholders' Equity - Fair Value of Employee HTML 20K Stock Options (Parenthetical) (Detail) 34: R24 Stockholders' Equity - Fair Value of Employee HTML 37K Stock Purchase Plan (Detail) 35: R25 Stockholders' Equity - Preferred Stock - HTML 22K Additional Information (Detail) 36: R26 Stockholders' Equity - Common Stock - Additional HTML 64K Information (Detail) 37: R27 Stockholders' Equity - Restricted Stock Awards, HTML 87K Restricted Stock Units and Performance-Based Restricted Stock Units - Additional Information (Detail) 38: R28 Stockholders' Equity - Summary of Company's HTML 48K Restricted Stock Unit Activity and Performance-Based Restricted Stock Unit Activity (Detail) 39: R29 Stockholders' Equity - Summary of Stock Option HTML 53K Activity (Detail) 40: R30 Stockholders' Equity - Stock Options and Employee HTML 53K Stock Purchase Plan - Additional Information (Detail) 41: R31 Stockholders' Equity - Summary of Warrant Activity HTML 44K (Detail) 42: R32 Stockholders' Equity - Warrants - Additional HTML 28K Information (Detail) 43: R33 Stockholders' Equity - Common Stock Reserved for HTML 38K Future Issuance (Detail) 44: R34 Collaborative Research, Development, and License HTML 43K Agreements - Additional Information (Detail) 45: R35 Leases - Additional Information (Details) HTML 55K 46: R36 Leases - Schedule of Impact of Adoption of ASC 842 HTML 43K on Consolidated Balance Sheet (Details) 47: R37 Leases - Summary of Lease Liabilities and HTML 37K Corresponding Right-of-use assets (Details) 48: R38 Leases - Summary of Cash Flows Associated with HTML 20K Company's Leases (Details) 49: R39 Leases - Future Lease Payments Relating to HTML 43K Operating Lease Liabilities (Detail) 50: R40 Related Parties - Additional Information (Detail) HTML 35K 51: R41 Subsequent Events - Additional Information HTML 39K (Detail) 53: XML IDEA XML File -- Filing Summary XML 95K 52: EXCEL IDEA Workbook of Financial Reports XLSX 61K 5: EX-101.INS XBRL Instance -- onvo-20190630 XML 1.22M 7: EX-101.CAL XBRL Calculations -- onvo-20190630_cal XML 104K 8: EX-101.DEF XBRL Definitions -- onvo-20190630_def XML 439K 9: EX-101.LAB XBRL Labels -- onvo-20190630_lab XML 894K 10: EX-101.PRE XBRL Presentations -- onvo-20190630_pre XML 709K 6: EX-101.SCH XBRL Schema -- onvo-20190630 XSD 123K 54: ZIP XBRL Zipped Folder -- 0001564590-19-030763-xbrl Zip 111K
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Organovo Holdings, Inc. (the “Company”) for the period ended June 30, 2019, as filed with the Securities and Exchange Commission (the “Report”), I, Taylor Crouch, Chief Executive Officer and President and I, Craig Kussman, Chief Financial Officer of the Company hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
• |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
• |
The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: August 8, 2019
/s/ Taylor Crouch |
Chief Executive Officer and President (Principal Executive Officer) |
/s/ Craig Kussman |
Chief Financial Officer (Principal Financial Officer) |
A signed original of this written statement required by Section 906 has been provided to Organovo Holdings, Inc. and will be retained by Organovo Holdings, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission, and is not to be incorporated by reference into any filing of Organovo Holdings, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 8/8/19 | None on these Dates | ||
For Period end: | 6/30/19 | |||
List all Filings |